Dynamic Partnership between TFIIH, PGC-1α and SIRT1 Is Impaired in Trichothiodystrophy

PLoS Genetics

Volumn 10, Issue 10, 2014, Pages

  Traboulsi, Hussein ^a   Davoli, Serena ^a   Catez, Philippe ^a   Egly, Jean Marc ^a   Compe, Emmanuel ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SIRTUIN 1; TRANSCRIPTION FACTOR IIA; PPARGC1A PROTEIN, MOUSE; SIRT1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR IIH;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DIET RESTRICTION; ENERGY BALANCE; FOOD DEPRIVATION; GENE EXPRESSION REGULATION; GENE TARGETING; GLUCONEOGENESIS; LIVER PARENCHYMA; MALE; MOLECULAR PATHOLOGY; MOUSE; MOUSE MODEL; NONHUMAN; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRICHOTHIODYSTROPHY; WILD TYPE; ANIMAL; BIOSYNTHESIS; DNA REPAIR; GENETIC TRANSCRIPTION; GENETICS; HUMAN; LIVER CELL; METABOLISM; PATHOLOGY;

ANIMALS; DNA REPAIR; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; MICE; SIRTUIN 1; TRANSCRIPTION FACTOR TFIIH; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRICHOTHIODYSTROPHY SYNDROMES;

EID: 84908353548     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004732     Document Type: Article

References (53)

1. Brivanlou AH, Darnell JE, Jr (2002) Signal transduction and the control of gene expression. Science 295: 813–818.
2. Thomas MC, Chiang CM, (2006) The general transcription machinery and general cofactors. Crit Rev Biochem Mol Biol 41: 105–178.
3. Jitrapakdee S, (2012) Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis. Int J Biochem Cell Biol 44: 33–45.
4. Mayr B, Montminy M, (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2: 599–609.
5. Koo SH, Flechner L, Qi L, Zhang X, Screaton RA, et al. (2005) The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437: 1109–1111.
6. Park EA, Roesler WJ, Liu J, Klemm DJ, Gurney AL, et al. (1990) The role of the CCAAT/enhancer-binding protein in the transcriptional regulation of the gene for phosphoenolpyruvate carboxykinase (GTP). Mol Cell Biol 10: 6264–6272.
7. Schmoll D, Walker KS, Alessi DR, Grempler R, Burchell A, et al. (2000) Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity. J Biol Chem 275: 36324–36333.
8. Hall RK, Yamasaki T, Kucera T, Waltner-Law M, O'Brien R, et al. (2000) Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The role of winged helix/forkhead proteins. J Biol Chem 275: 30169–30175.
9. Rhee J, Inoue Y, Yoon JC, Puigserver P, Fan M, et al. (2003) Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc Natl Acad Sci U S A 100: 4012–4017.
10. Imai E, Stromstedt PE, Quinn PG, Carlstedt-Duke J, Gustafsson JA, et al. (1990) Characterization of a complex glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 10: 4712–4719.
11. Schoneveld OJ, Gaemers IC, Lamers WH, (2004) Mechanisms of glucocorticoid signalling. Biochim Biophys Acta 1680: 114–128.
12. Yubero P, Hondares E, Carmona MC, Rossell M, Gonzalez FJ, et al. (2004) The developmental regulation of peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression in the liver is partially dissociated from the control of gluconeogenesis and lipid catabolism. Endocrinology 145: 4268–4277.
13. Herzog B, Hall RK, Wang XL, Waltner-Law M, Granner DK, (2004) Peroxisome proliferator-activated receptor gamma coactivator-1alpha, as a transcription amplifier, is not essential for basal and hormone-induced phosphoenolpyruvate carboxykinase gene expression. Mol Endocrinol 18: 807–819.
14. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, et al. (2001) Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413: 131–138.
15. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, et al. (2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434: 113–118.
16. Nemoto S, Fergusson MM, Finkel T, (2005) SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J Biol Chem 280: 16456–16460.
17. Compe E, Egly JM, (2012) TFIIH: when transcription met DNA repair. Nat Rev Mol Cell Biol 13: 343–354.
18. Coin F, Marinoni JC, Rodolfo C, Fribourg S, Pedrini AM, et al. (1998) Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nat Genet 20: 184–188.
19. Bradsher J, Coin F, Egly JM, (2000) Distinct roles for the helicases of TFIIH in transcript initiation and promoter escape. J Biol Chem 275: 2532–2538.
20. Lu H, Zawel L, Fisher L, Egly JM, Reinberg D, (1992) Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II. Nature 358: 641–645.
21. Compe E, Drane P, Laurent C, Diderich K, Braun C, et al. (2005) Dysregulation of the Peroxisome Proliferator-Activated Receptor Target Genes by XPD Mutations. Mol Cell Biol 25: 6065–6076.
22. Compe E, Malerba M, Soler L, Marescaux J, Borrelli E, et al. (2007) Neurological defects in trichothiodystrophy reveal a coactivator function of TFIIH. Nat Neurosci 10: 1414–1422.
23. Broughton BC, Steingrimsdottir H, Weber CA, Lehman AR, (1994) Mutations in the xeroderma pigmentosum group D DNA repair/transcription gene in patients with trichothiodystrophy. Nature gnetics 7: 189–194.
24. de Boer J, de Wit J, van Steeg H, Berg R, Morreau H, et al. (1998) A mouse model for the basal transcription/DNA repair syndrome trichothiodystrophy. Mol Cell 1(7): 981–990.
25. Itin PH, Pittelkow MR, (1990) Trichothiodystrophy: review of sulfur-deficient brittle hair syndromes and association with the ectodermal dysplasias. J Am Acad Dermatol 22: 705–717.
26. Faghri S, Tamura D, Kraemer KH, Digiovanna JJ, (2008) Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations. J Med Genet 45: 609–621.
27. Lehmann AR, Arlett CF, Broughton BC, Harcourt SA, Steingrimsdottir H, et al. (1988) Trichothiodystrophy, a human DNA repair disorder with heterogeneity in the cellular response to ultraviolet light. Cancer Res 48: 6090–6096.
28. Sokolovic M, Sokolovic A, Wehkamp D, Ver Loren van Themaat E, de Waart DR, et al. (2008) The transcriptomic signature of fasting murine liver. BMC Genomics 9: 528.
29. Minassian C, Ajzannay A, Riou JP, Mithieux G, (1994) Investigation of the mechanism of glycogen rebound in the liver of 72-hour fasted rats. J Biol Chem 269: 16585–16588.
30. Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, et al. (2003) Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423: 550–555.
31. Herzig S, Long F, Jhala US, Hedrick S, Quinn R, et al. (2001) CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413: 179–183.
32. Botta E, Nardo T, Lehmann AR, Egly JM, Pedrini AM, et al. (2002) Reduced level of the repair/transcription factor TFIIH in trichothiodystrophy. Hum Mol Genet 11: 2919–2928.
33. Puigserver P, Wu Z, Park CW, Graves R, Wright M, et al. (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92: 829–839.
34. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, et al. (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98: 115–124.
35. Sano M, Izumi Y, Helenius K, Asakura M, Rossi DJ, et al. (2007) Menage-a-Trois 1 Is Critical for the Transcriptional Function of PPARgamma Coactivator 1. Cell Metab 5: 129–142.
36. Haigis MC, Sinclair DA, (2010) Mammalian sirtuins: biological insights and disease relevance. Annual review of pathology 5: 253–295.
37. Solomon JM, Pasupuleti R, Xu L, McDonagh T, Curtis R, et al. (2006) Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Molecular and cellular biology 26: 28–38.
38. Dubaele S, Proietti De Santis L, Bienstock RJ, Keriel A, Stefanini M, et al. (2003) Basal transcription defect discriminates between xeroderma pigmentosum and trichothiodystrophy in XPD patients. Mol Cell 11: 1635–1646.
39. Guzder SN, Sung P, Bailly V, Prakash L, Prakash S, (1994) RAD25 is a DNA helicase required for DNA repair and RNA polymerase II transcription. Nature 369: 578–581.
40. Moreland RJ, Tirode F, Yan Q, Conaway JW, Egly JM, et al. (1999) A role for the TFIIH XPB DNA helicase in promoter escape by RNA polymerase II. J Biol Chem 274: 22127–22130.
41. Oksenych V, de Jesus BB, Zhovmer A, Egly JM, Coin F, (2009) Molecular insights into the recruitment of TFIIH to sites of DNA damage. EMBO J 28: 2971–2980.
42. Fan L, Arvai AS, Cooper PK, Iwai S, Hanaoka F, et al. (2006) Conserved XPB core structure and motifs for DNA unwinding: implications for pathway selection of transcription or excision repair. Mol Cell 22: 27–37.
43. Keriel A, Stary A, Sarasin A, Rochette-Egly C, Egly JM, (2002) XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha. Cell 109: 125–135.
44. Sasaki T, Maier B, Koclega KD, Chruszcz M, Gluba W, et al. (2008) Phosphorylation regulates SIRT1 function. PLoS One 3: e4020.
45. Gerhart-Hines Z, Dominy JE, JrBlattler SM, Jedrychowski MP, Banks AS, et al. (2011) The cAMP/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD(+). Molecular cell 44: 851–863.
46. Houtkooper RH, Pirinen E, Auwerx J, (2012) Sirtuins as regulators of metabolism and healthspan. Nature reviews Molecular cell biology 13: 225–238.
47. Chalkiadaki A, Guarente L, (2012) Sirtuins mediate mammalian metabolic responses to nutrient availability. Nature reviews Endocrinology 8: 287–296.
48. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, et al. (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011–2015.
49. Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, et al. (2004) Mammalian SIRT1 represses forkhead transcription factors. Cell 116: 551–563.
50. Velez-Cruz R, Zadorin AS, Coin F, Egly JM (2012) Sirt1 suppresses RNA synthesis after UV irradiation in combined xeroderma pigmentosum group D/Cockayne syndrome (XP-D/CS) cells. Proc Natl Acad Sci U S A.
51. Kamiya A, Kinoshita T, Ito Y, Matsui T, Morikawa Y, et al. (1999) Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. EMBO J 18: 2127–2136.
52. Kinoshita T, Sekiguchi T, Xu MJ, Ito Y, Kamiya A, et al. (1999) Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis. Proc Natl Acad Sci U S A 96: 7265–7270.
53. Ueda T, Compe E, Catez P, Kraemer KH, Egly JM, (2009) Both XPD alleles contribute to the phenotype of compound heterozygote xeroderma pigmentosum patients. J Exp Med 206: 3031–3046.